CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,170,634 | -75.9% | 135,947 | -70.3% | 0.01% | -76.0% |
| Q2 2023 | $25,656,428 | +3503.4% | 457,008 | +4095.4% | 0.05% | +2400.0% |
| Q3 2022 | $712,000 | -97.5% | 10,893 | -95.7% | 0.00% | -98.3% |
| Q3 2021 | $28,624,000 | +35238.3% | 255,727 | +13240.0% | 0.12% | +11800.0% |
| Q1 2020 | $81,000 | -44.1% | 1,917 | -19.3% | 0.00% | 0.0% |
| Q4 2019 | $145,000 | -31.6% | 2,374 | -48.7% | 0.00% | -88.9% |
| Q1 2018 | $212,000 | – | 4,627 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |